Golpimec (Fingolimod)

Golpimec is prescribed for patients with relapsing‑remitting multiple sclerosis (RRMS) to reduce the frequency of clinical relapses and to slow disease progression.

• Reduces annualized relapse rate in RRMS.
• Delays accumulation of disability.
• May be used as first‑line or escalation therapy.
• Administered orally once daily.
• Typically considered for adults with a confirmed diagnosis of RRMS.
• May be selected when disease‑modifying therapy is indicated.

Golpimec can cause a range of side effects, some of which are common and others that require prompt medical attention.

Common

• Headache
• Upper respiratory tract infection
• Diarrhea
• Elevated liver enzymes
• Fatigue
• Nasopharyngitis

Serious

• Bradycardia or other cardiac conduction abnormalities
• Severe infections (e.g., herpes zoster)
• Macular edema
• Liver injury
• Progressive multifocal leukoencephalopathy (PML) (rare)
• Severe skin reactions (e.g., Stevens‑Johnson syndrome)

Before starting Golpimec, several safety considerations should be reviewed.

• Contraindicated in pregnancy (Category X) and requires effective contraception.
• Baseline cardiac assessment is recommended due to potential bradycardia.
• Monitor liver function tests regularly.
• Screen for infections, especially varicella‑zoster, before initiation.
• Vaccinations should be administered at least 4 weeks prior to therapy.
• Caution in patients with a history of macular edema; ophthalmologic exams are advised.
• Discontinue if severe adverse reactions occur.

Golpimec may interact with other medicines, influencing its safety and effectiveness.

Avoid

• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) that can increase fingolimod exposure.
• Live vaccines during treatment and for at least 2 months after discontinuation.
• Other immunosuppressive agents that may heighten infection risk.

Use with caution

• CYP3A4 inducers (e.g., rifampin, carbamazepine) which may reduce efficacy.
• Antihypertensive drugs that could exacerbate bradycardia.
• Drugs affecting cardiac conduction (e.g., amiodarone, beta‑blockers).
• Medications known to cause macular edema.